Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35380669.
- Also identified by DOI 10.1158/1078-0432.CCR-22-0884.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus-associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm. See related article by Reid et al., p. 2646.
Medical subject headings
- HIV Infections
- Sarcoma, Kaposi